EU panel recommends phased approach to assess risk from medical devices using nanomaterials
This article was originally published in SRA
Executive Summary
The European Commission's scientific committee on new and emerging risks, SCENIHR, has issued its final guidance on the risk assessment of medical devices that incorporate nanomaterials1-3. To avoid unnecessary testing of such devices, SCENIHR recommends a four-step approach to carry out the risk assessment process.